- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02956902
A Smartphone Intervention With Telemedicine Support for Management of Post-traumatic Stress Disorder: A Randomized Trial
April 14, 2023 updated by: Ontario Shores Centre for Mental Health Sciences
This study tests whether people receiving clinician support to use a mobile application on their smartphone can manage their post-traumatic stress disorder (PTSD) symptoms better than those who do not.
Half of the participants will receive the clinician supported smartphone application intervention and the other half will remain on the waiting list.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
67
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
25 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- on the waiting list for the Ontario Shores traumatic stress clinic;
- score ≥ 31 on the PCL-5
- have access to a smartphone or tablet to which they are willing to download the app.
Exclusion Criteria:
- active suicidal ideation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Waiting list control
|
|
|
Experimental: Intervention
Clinician-supported smartphone application intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in PTSD symptom severity
Time Frame: 8 weeks
|
Change in PTSD checklist (PCL-5) score
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinically significant change in PTSD symptom severity
Time Frame: 8 weeks
|
Proportion of participants with a PCL-5 score less than 31
|
8 weeks
|
|
Change in Depression Severity
Time Frame: 8 week
|
Change in patient health questionnaire 9 (PHQ-9) score
|
8 week
|
|
Average App Use per Week (Intervention group only)
Time Frame: 8 weeks
|
Self-report app use will be collected by the clinician at each of sessions 2-4 by asking "on average, how many times did you use the app per day (or per week, if less than once per day).
The clinician will also ask which of the four main functions were used and which symptom management tools were used most and were most helpful.
|
8 weeks
|
|
Goal Achievement (Intervention group only)
Time Frame: 8 weeks
|
At each of sessions 1-3, the clinician will help the participant set goals, which will be documented.
At each of sessions 2-4 the clinician will ask the participant to self-report goal achievement, which will be documented
|
8 weeks
|
|
Clinician Fidelity to Protocol
Time Frame: 8 weeks
|
A fidelity checklist has been created for this protocol, which will be completed over the course of the intervention.
The form will be updated upon completion of each clinician session.
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
December 1, 2016
Primary Completion (Actual)
April 1, 2017
Study Completion (Actual)
April 1, 2017
Study Registration Dates
First Submitted
November 3, 2016
First Submitted That Met QC Criteria
November 3, 2016
First Posted (Estimate)
November 6, 2016
Study Record Updates
Last Update Posted (Actual)
April 18, 2023
Last Update Submitted That Met QC Criteria
April 14, 2023
Last Verified
April 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16-107IF
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.